Barbara Ann Karmanos Cancer Institute
02/25/2026 | Press release | Archived content
IN THE NEWS – Cancer Treatment Revolution: The Device That Could Change Everything
February 25, 2026
OncoDaily
OncoDaily host, Roupen Odabashian, M.D., FRCPC, FASCO, hematology oncology fellow at Karmanos, interviewed Boris Pasche, M.D., Ph.D., FACP, CEO and president of the Barbara Ann Karmanos Cancer Institute, and Anthony Shields, M.D., Ph.D., associate center director for Clinical Sciences, member of the Gastrointestinal and Neuroendocrine Oncology Multidisciplinary Team (MDT), the Phase I Clinical Trials MDT, and the Molecular Therapeutics Researcher Program, about the TheraBionic P1 device. Learn how the idea came about to treat cancer with radiofrequency electromagnetic fields, studies behind this revolutionary treatment and how Karmanos is continue studies in treating cancer with this at-home treatment.
Watch the podcast episode here.
Boris Pasche, M.D., Ph.D., FACP
Anthony Shields, M.D., Ph.D.
Roupen Odabashian, M.D., FRCPC, FASCO
Barbara Ann Karmanos Cancer Institute published this content on February 25, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on March 24, 2026 at 12:14 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]